FDA approved the Amplatzer Paraclose PVL Occluder from ABBOTT MEDICAL on Oct 27, 2026 under P260019, an original premarket approval. The review panel was Cardiovascular.

FDA logged the submission as received on Apr 30, 2026. The decision came 180 days later.

ABBOTT MEDICAL has 8 other decisions in the tracker over the last 12 months: K261729 (EnSite™ X EP System), K262006 (EnSite™ X EP System), K261825 (Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter), K261631 (Amplatzer TorqVue Exchange System).